Schröder R, Lefèvre J P, Nowak P. "Method for the Synthesis of 7367-79-5
BAT
Behenic acid tryptamide
Docosanoic acid tryptamide
N-Docosanoyltryptamine
N-[2-(3-Indolyl)ethyl]docosanamide" [P]. European Patent, EP 3069018 A1, 2015-02-13.
Jørgensen K, Lefèvre J P, Schröder R. "A Process for Preparing High-Purity 7367-79-5
BAT
Behenic acid tryptamide
Docosanoic acid tryptamide
N-Docosanoyltryptamine
N-[2-(3-Indolyl)ethyl]docosanamide" [P]. European Patent, EP 3192234 A1, 2019-03-25.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 二十二烷酸色酰胺 in Pharmaceutical Formulations". Sci. Total Environ., 2024, 1386, (8), 435-463.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 二十二烷酸色酰胺 as an Impurity". Environ. Sci. Technol., 2016, 116, (11), 7725-7739.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 7367-79-5
BAT
Behenic acid tryptamide
Docosanoic acid tryptamide
N-Docosanoyltryptamine
N-[2-(3-Indolyl)ethyl]docosanamide Using HRMS and NMR". Molecules, 2015, 1296, (1), 3704-3707.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 二十二烷酸色酰胺 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2021, 387, (3), 9815-9845.